VYNE: VYNE Therapeutics Inc. Stock

by  •  • Comments Off on VYNE: VYNE Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 19.28
Enterprise Value ($M) -8.93
Book Value ($M) 44.13
Book Value / Share 2.98
Price / Book 0.44
NCAV ($M) 42.62
NCAV / Share 2.87
Price / NCAV 0.45

Profitability (mra)
Return on Invested Capital (ROIC) -0.95
Return on Assets (ROA) -0.46
Return on Equity (ROE) -0.51

Liquidity (mrq)
Quick Ratio 4.47
Current Ratio 4.47

Balance Sheet (mrq) ($M)
Current Assets 54.91
Assets 56.42
Liabilities 12.29
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.50
Operating Income -43.64
Net Income -39.83
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -33.97
Cash from Investing 23.36
Cash from Financing -0.14

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Soleus Capital Master Fund, L.P. 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2025-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-08 4,998 216,740 2.31
2025-05-07 5,366 258,506 2.08
2025-05-06 16,207 114,038 14.21
2025-05-05 21,742 128,821 16.88

(click for more detail)

Similar Companies
VTGN – Vistagen Therapeutics, Inc. VTVT – vTv Therapeutics Inc.
VXRT – Vaxart, Inc. WHWK – Whitehawk Therapeutics, Inc.
WINT – Windtree Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io